Cytori Therapeutics Completes Development of the Celution(TM) System
To Submit CE Mark Application for European Approval
The CelutionTM System will extract and concentrate a significant number of stem and regenerative cells from adipose tissue harvested by a physician in a simple liposuction procedure. The cells can then be administered to the same patient where tissue repair or regeneration is needed. Due to the abundance of stem cells residing in adipose tissue, external cell manufacturing or cell culture is not required to multiply an otherwise very rare cell population. Cytori's proprietary technology allows for a real-time process wherein a patient can receive their own regenerative cells in about an hour. By utilizing the patient's own cells, the need to use embryonic stem cells and cells from other donors is avoided.
Most read news
Organizations
Other news from the department research and development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.